Mucopolysaccharidosis VII

4

Review clinical trials related to Mucopolysaccharidosis VII. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Mucopolysaccharidosis VII Disease Monitoring Program

The objectives of this study are to characterize MPS VII disease presentation and progression and assess long-term effectiveness and safety, including hypersensitivity reactions and immunogenicity of vestronidase alfa.

Participants needed: 50
Trial details
Biological sex: AllType: ObservationalSponsor: Ultragenyx Pharmaceutical IncUpdated: Jun 11, 2026Locations: 14
Eligibility criteria

Diagnosis of MPS VII based on laboratory diagnosis, including either enzymatic o... [+2]

Concurrent participation in other pharmaceutical company-sponsored interventiona...

Status: Recruiting

Registry of Patients Diagnosed With Lysosomal Storage Diseases

This is an international prospective and retrospective registry of patients with Lysosomal Storage Diseases (LSDs) to understand the natural history of the disease and the outcomes of fetal therapies, with the overall goal of improving the prenatal management of patients with LSDs.

Participants needed: 250
Trial details
Age: Up to 64Biological sex: AllType: ObservationalSponsor: University of California, San FranciscoUpdated: Apr 8, 2026Locations: 1Duration: 15 Years
Eligibility criteria

Patients aged 0-64 with a diagnosis of a lysosomal storage disease [+1]

There are no current exclusion criteria

Status: Available

Expanded Access to Mepsevii

Individual patient expanded access requests may be considered for patients who have no other treatment options

Trial details
Biological sex: AllType: Expanded AccessSponsor: Ultragenyx Pharmaceutical IncUpdated: Apr 7, 2026
Eligibility criteria

Not listed

Status: Recruiting

MPS (RaDiCo Cohort) (RaDiCo-MPS)

The goal of this observational study is to characterize the epidemiology and natural history of MPS diseases by building a retrospective and prospective collection of extensive phenotypic data from French MPS patients.

Participants needed: 1,000
Trial details
Biological sex: AllType: ObservationalSponsor: Institut National de la Santé Et de la Recherche Médicale, FranceUpdated: Feb 11, 2026Locations: 23
Eligibility criteria

Confirmed diagnosis of MPS based on clinically relevant enzyme deficiency, with... [+1]